Roche touts Phase 3 Susvi­mo da­ta in di­a­betes-re­lat­ed oph­thalmic dis­eases

Roche has un­veiled new two-year da­ta from late-stage stud­ies of its oc­u­lar im­plant Susvi­mo in pa­tients with di­a­bet­ic eye con­di­tions, as the Swiss phar­ma works …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER